U.S. Expresses Concern Over India’s Proposal To Allow More Generic Drug Production

Reuters: U.S. fears for patents on next-generation drugs in India
“The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent…” (Busvine/Siddiqui, 3/6).